The resulting signature comprised four genes: SOCS2, IL2RA, NPDC1, and PHGDH. Its elevated expression was an independent prognostic parameter for poor overall survival in several independent AML cohorts [39]. This evidence concerns the gene NPDC1 and acute myeloid leukemia.